Ovid Therapeutics (OVID) Depreciation & Amortization (CF) (2016 - 2026)
Ovid Therapeutics (OVID) posted Depreciation & Amortization (CF) of $35000.0 for Q1 2026, up 105.88% on a QoQ basis from $17000.0 in Q4 2025, and down 75.18% year-over-year from $141000.0 in Q1 2025.
Ovid Therapeutics (OVID) Depreciation & Amortization (CF) (2016 - 2026) Analysis & Trends
Ovid Therapeutics' Depreciation & Amortization (CF) history runs 11 years deep, the most recent figure standing at $35000.0 for Q1 2026.
- Quarterly Depreciation & Amortization (CF) fell 75.18% year-over-year to $35000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $167000.0 (down 72.98% YoY) and the FY2025 annual result came in at $273000.0, down 55.46% from the prior year.
- Depreciation & Amortization (CF) was $35000.0 for Q1 2026 at Ovid Therapeutics, up from $17000.0 in the prior quarter.
- Across five years, Depreciation & Amortization (CF) topped out at $184980.0 in Q4 2022 and bottomed at $16000.0 in Q3 2025.
- A 5-year average of $117735.6 and a median of $140000.0 in 2023 frame the typical range for Depreciation & Amortization (CF).
- Annual changes were most pronounced in 2022 — Depreciation & Amortization (CF) soared 224.81% — and 2025, when it slumped 90.53%.
- Ovid Therapeutics' Depreciation & Amortization (CF) stood at $184980.0 in 2022, then slipped by 24.32% to $140000.0 in 2023, then gained by 14.29% to $160000.0 in 2024, then sank by 89.38% to $17000.0 in 2025, then soared by 105.88% to $35000.0 in 2026.
- Business Quant data shows OVID's Depreciation & Amortization (CF) at $35000.0 in Q1 2026, $17000.0 in Q4 2025, and $16000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | 196,658.72 |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 41.14 Mn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 55.90 Mn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | 123.20 Mn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | 2.20 Mn |
| 10 | Ovid Therapeutics | 118.66 Mn | -36.86 Mn | - | 35,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 35,000.00 |
| Mar 31, 2026 | 35,000.00 |
| Dec 31, 2025 | 17,000.00 |
| Dec 31, 2025 | 17,000.00 |
| Sep 30, 2025 | 16,000.00 |
| Sep 30, 2025 | 16,000.00 |
| Jun 30, 2025 | 99,000.00 |
| Jun 30, 2025 | 99,000.00 |
| Mar 31, 2025 | 141,000.00 |
| Mar 31, 2025 | 141,000.00 |
| Dec 31, 2024 | 160,000.00 |
| Dec 31, 2024 | 160,000.00 |
| Sep 30, 2024 | 169,000.00 |
| Sep 30, 2024 | 169,000.00 |
| Jun 30, 2024 | 148,000.00 |
| Jun 30, 2024 | 148,000.00 |
| Mar 31, 2024 | 136,000.00 |
| Mar 31, 2024 | 136,000.00 |
| Dec 31, 2023 | 140,000.00 |
| Dec 31, 2023 | 140,000.00 |